THE ANALYSIS STUDY OF ASSOCIATION PERSISTENT SMOKING AND LONG TERM OUTCOMES IN PATIENTS WITH ATRIAL FIBRILATION: A COMPREHENSIVE SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/1chhdb69Keywords:
Smoking, risk, atrial fibrillationAbstract
Background: Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide, with an estimated 5 million new cases reported in 2010 and a prevalence of 33 million by 2015. Over the past two decades, numerous prospective epidemiological studies have investigated the link between smoking and AF. This systematic review aims to evaluate the association persistent smoking and long term outcomes in patients with atrial fibrilation by analyzing available studies of the last 10 years.
Methods: The study adhered to PRISMA 2020 standards, examining English literature from 2014 to 2024. It excluded editorials, reviews from the same journal, and submissions without a DOI. PubMed, SagePub, SpringerLink, and Google Scholar were utilized as literature sources.
Result: Initially retrieving 360 articles from online databases (PubMed, SagePub, SpringerLink and Google Scholar) eight relevant papers were selected after three rounds of screening for full-text analysis.
Conclusion: Smoking is generally associated with an increased risk of AF. The extent of this risk is influenced by various factors, including age, gender, and other cardiovascular risk factors. These findings underline the importance of a nuanced approach to AF prevention and treatment, particularly concerning smoking habits.
References
O’Keefe EL, Sturgess JE, O’Keefe JH, Gupta S, Lavie CJ. Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification. Am J Cardiol. 2021;160:46-52. doi:10.1016/j.amjcard.2021.08.042
Hong KL, Glover BM. The impact of lifestyle intervention on atrial fibrillation. Curr Opin Cardiol. 2018;33(1):14-19. doi:10.1097/HCO.0000000000000470
Kozieł M, Teutsch C, Halperin JL, et al. Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF. PloS One. 2021;16(4):e0249524. doi:10.1371/journal.pone.0249524
Almutairi AR, Zhou L, Gellad WF, et al. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Clin Ther. 2017;39(7):1456-1478.e36. doi:10.1016/j.clinthera.2017.05.358
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation. BMC Geriatr. 2024;24(1):619. doi:10.1186/s12877-024-05186-9
Wan Q, Li S, Hu J. Association of smoking with postoperative atrial fibrillation in patients with cardiac surgery: A PRISMA-compliant article. Medicine (Baltimore). 2021;100(23):e26179. doi:10.1097/MD.0000000000026179
Chatterjee NA, Chae CU, Kim E, et al. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation. JACC Heart Fail. 2017;5(8):552-560. doi:10.1016/j.jchf.2017.04.004
Tsai CF, Anderson N, Thomas B, Sudlow CLM. Risk factors for ischemic stroke and its subtypes in Chinese vs. Caucasians: Systematic review and meta-analysis. Int J Stroke Off J Int Stroke Soc. 2015;10(4):485-493. doi:10.1111/ijs.12508
Mons U, Müezzinler A, Gellert C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551. doi:10.1136/bmj.h1551
Knuiman M, Briffa T, Divitini M, et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol. 2014;29(3):181-190. doi:10.1007/s10654-013-9875-y
Tzeis S, Gerstenfeld EP, Kalman J, et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. Published online April 8, 2024. doi:10.1016/j.hrthm.2024.03.017
Plank B, Kutyifa V, Moss AJ, et al. Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: A MADIT-CRT substudy. Heart Rhythm. 2014;11(5):822-827. doi:10.1016/j.hrthm.2014.02.007
Son MK, Song DS, Lee K, Park HY. Lower number of modifiable risk factors was associated with reduced atrial fibrillation incidence in an 18-year prospective cohort study. Sci Rep. 2022;12(1):9207. doi:10.1038/s41598-022-13434-4
Nath M, Swarnkar P, Sharma R, Kumar A, Misra S, Kumar P. Association of modifiable risk factors with ischaemic stroke subtypes in Asian versus Caucasian populations: A systematic review and meta-analysis. Eur J Clin Invest. 2022;52(11):e13849. doi:10.1111/eci.13849
Lubitz SA, Yin X, Rienstra M, et al. Long-Term Outcomes of Secondary Atrial Fibrillation in the Community. Circulation. 2015;131(19):1648-1655. doi:10.1161/CIRCULATIONAHA.114.014058
Albertsen IE, Rasmussen LH, Lane DA, et al. The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation. Chest. 2014;145(3):559-566. doi:10.1378/chest.13-1740
Suzuki S, Otsuka T, Sagara K, et al. Association between smoking habits and the first-time appearance of atrial fibrillation in Japanese patients: Evidence from the Shinken Database. J Cardiol. 2015;66(1):73-79. doi:10.1016/j.jjcc.2014.09.010
Zuo H, Nygård O, Vollset SE, et al. Smoking, plasma cotinine and risk of atrial fibrillation: the Hordaland Health Study. J Intern Med. 2018;283(1):73-82. doi:10.1111/joim.12689
Imtiaz Ahmad M, Mosley CD, O’Neal WT, et al. Smoking and risk of atrial fibrillation in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Cardiol. 2018;71(2):113-117. doi:10.1016/j.jjcc.2017.07.014
Lee SR, Choi EK, Jung JH, Han KD, Oh S, Lip GYH. Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death. J Clin Med. 2021;10(11):2238. doi:10.3390/jcm10112238
Kwon Y, Norby FL, Jensen PN, et al. Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS). PLOS ONE. 2016;11(1):e0147065. doi:10.1371/journal.pone.0147065
Wu Z, Tang C, Wang D. Bidirectional two-sample Mendelian randomization study of association between smoking initiation and atrial fibrillation. Tob Induc Dis. 2024;22:10.18332/tid/189380. doi:10.18332/tid/189380
Holmqvist F, Guan N, Zhu Z, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647-654.e2. doi:10.1016/j.ahj.2014.12.024
Watanabe I. Smoking and risk of atrial fibrillation. J Cardiol. 2018;71(2):111-112. doi:10.1016/j.jjcc.2017.08.001
Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol. 2018;25(13):1437-1451. doi:10.1177/2047487318780435
Zhu W, Yuan P, Shen Y, Wan R, Hong K. Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies. Int J Cardiol. 2016;218:259-266. doi:10.1016/j.ijcard.2016.05.013
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Fikar Ramadhani, Nabila Luthfiyyah Zahra, Akhmad Reza Pahlevi (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
